Patrick Lin - 01 Apr 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Reporting relationship: Chief Business - Strategy Off
Issuer ticker: PCSA
Reported as of: 01 Apr 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Apr 2022, 17:51:06 UTC
Prior SEC filing: 06 Jan 2022
Next SEC filing: 08 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact

Key filing fact

Patrick Lin filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 11 Apr 2022.

Key facts

This page summarizes Patrick Lin's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Apr 2022, 17:51.

Change

Previous filing in this sequence was filed on 06 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCSA transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +247,841
Change %: +451%
Price: $0.000000
Shares after: 302,766
Date: 01 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 247,841
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the "Plan") to increase the authorized shares under the Plan.

Footnote F2

The previous filing understated this number. This new total accurately reflects the cumulative total of Restricted Stock Units for the reporting person.